Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-amphetamine | increases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Dextroamphetamine results in increased expression of HNRNPH3 mRNA | CTD | PMID:12558987 | 1,2-dimethylhydrazine | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of HNRNPH3 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of HNRNPH3 mRNA | CTD | PMID:35192832 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Metribolone results in decreased expression of HNRNPH3 protein | CTD | PMID:17152098 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21215274 | 3,3',5-triiodo-L-thyronine | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Triiodothyronine results in increased expression of HNRNPH3 mRNA | CTD | PMID:23397585 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HNRNPH3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HNRNPH3 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases methylation | ISO | HNRNPH3 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of HNRNPH3 gene | CTD | PMID:31601247 | 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Oxazolone results in increased expression of HNRNPH3 mRNA | CTD | PMID:11379042 | aflatoxin B1 | increases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of HNRNPH3 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases methylation | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of HNRNPH3 gene | CTD | PMID:27153756 | all-trans-retinoic acid | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Tretinoin co-treated with Tamoxifen] results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 | all-trans-retinoic acid | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 | aristolochic acid A | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of HNRNPH3 mRNA | CTD | PMID:33212167 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of HNRNPH3 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of HNRNPH3 protein | CTD | PMID:20097212 | benzo[a]pyrene | increases methylation | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of HNRNPH3 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Soot co-treated with Benzo(a)pyrene] results in increased expression of HNRNPH3 protein modified form | CTD | PMID:24464499 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20678512 and PMID:29275510 | bisphenol A | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of HNRNPH3 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils more ... | CTD | PMID:28628672 and PMID:33376534 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of HNRNPH3 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HNRNPH3 mRNA | CTD | PMID:28628672 | bisphenol F | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of HNRNPH3 protein | CTD | PMID:34186270 | cadmium atom | multiple interactions | ISO | Hnrnph3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HNRNPH3 mRNA | CTD | PMID:37325564 | cadmium dichloride | multiple interactions | ISO | Hnrnph3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HNRNPH3 mRNA | CTD | PMID:37325564 | caffeine | decreases phosphorylation | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of HNRNPH3 protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of HNRNPH3 mRNA | CTD | PMID:37019170 | cisplatin | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of HNRNPH3 mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of HNRNPH3 mRNA | CTD | PMID:27392435 | copper atom | affects binding | ISO | HNRNPH3 (Homo sapiens) | 6480464 | HNRNPH3 protein binds to Copper | CTD | PMID:15359738 | copper(0) | affects binding | ISO | HNRNPH3 (Homo sapiens) | 6480464 | HNRNPH3 protein binds to Copper | CTD | PMID:15359738 | copper(II) sulfate | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of HNRNPH3 mRNA | CTD | PMID:19549813 | coumestrol | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of HNRNPH3 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20106945 more ... | dexamethasone | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HNRNPH3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HNRNPH3 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of HNRNPH3 mRNA | CTD | PMID:17361019 and PMID:21266533 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21551480 | dorsomorphin | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of HNRNPH3 mRNA | CTD | PMID:29391264 | enzyme inhibitor | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HNRNPH3 protein | CTD | PMID:23301498 | FR900359 | increases phosphorylation | ISO | HNRNPH3 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of HNRNPH3 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of HNRNPH3 mRNA | CTD | PMID:33387578 | hydrogen peroxide | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HNRNPH3 protein | CTD | PMID:18951874 | hydrogen peroxide | affects expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of HNRNPH3 mRNA | CTD | PMID:21179406 | indometacin | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HNRNPH3 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HNRNPH3 mRNA | CTD | PMID:28628672 | isoprenaline | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Isoproterenol results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20003209 | ivermectin | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of HNRNPH3 protein | CTD | PMID:32959892 | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of HNRNPH3 mRNA | CTD | PMID:20080153 | leflunomide | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of HNRNPH3 mRNA | CTD | PMID:28988120 | mercury atom | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Mercury results in increased expression of HNRNPH3 mRNA | CTD | PMID:16823088 | mercury(0) | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Mercury results in increased expression of HNRNPH3 mRNA | CTD | PMID:16823088 | methyl methanesulfonate | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of HNRNPH3 mRNA | CTD | PMID:23649840 | methylparaben | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | methylparaben results in increased expression of HNRNPH3 mRNA | CTD | PMID:31745603 | nonanoic acid | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | pelargonic acid results in decreased expression of HNRNPH3 mRNA | CTD | PMID:11379042 | paracetamol | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21420995 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of HNRNPH3 mRNA | CTD | PMID:33387578 | phenylmercury acetate | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of HNRNPH3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HNRNPH3 mRNA | CTD | PMID:27188386 | quercetin | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Quercetin results in increased expression of HNRNPH3 protein | CTD | PMID:17292933 | resorcinol | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | resorcinol results in increased expression of HNRNPH3 mRNA | CTD | PMID:22623647 | resveratrol | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPH3 mRNA | CTD | PMID:23557933 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of HNRNPH3 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | silicon dioxide | increases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of HNRNPH3 mRNA | CTD | PMID:25895662 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of HNRNPH3 protein | CTD | PMID:29459688 | sodium fluoride | decreases expression | ISO | Hnrnph3 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of HNRNPH3 protein | CTD | PMID:28918527 | succimer | multiple interactions | ISO | Hnrnph3 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH3 mRNA | CTD | PMID:21641980 | tamoxifen | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Tamoxifen results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 | tamoxifen | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Tretinoin co-treated with Tamoxifen] results in decreased expression of HNRNPH3 protein | CTD | PMID:17098229 | theophylline | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HNRNPH3 protein | CTD | PMID:18951874 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of HNRNPH3 mRNA | CTD | PMID:33387578 | trichostatin A | affects expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | trichostatin A affects the expression of HNRNPH3 mRNA | CTD | PMID:28542535 | valproic acid | affects expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of HNRNPH3 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | HNRNPH3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HNRNPH3 mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | ISO | HNRNPH3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of HNRNPH3 mRNA | CTD | PMID:23179753 more ... | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of HNRNPH3 mRNA | CTD | PMID:23034163 | |